Acta Neuropathol

1. FANCY NN, Smith AM, Caramello A, Tsartsalis S, et al
   Characterisation of premature cell senescence in Alzheimer's disease using single nuclear transcriptomics.
   Acta Neuropathol. 2024;147:78.
   

   >> Share

   
   

   
   Alzheimers Dement

2. PANDEY RS, Arnold M, Batra R, Krumsiek J, et al
   Metabolomics profiling reveals distinct, sex-specific signatures in serum and brain metabolomes in mouse models of Alzheimer's disease.
   Alzheimers Dement. 2024 Apr 27. doi: 10.1002/alz.13851.
   

   >> Share

   
   
3. EARNEST T, Bani A, Ha SM, Hobbs DA, et al
   Data-driven decomposition and staging of flortaucipir uptake in Alzheimer's disease.
   Alzheimers Dement. 2024 Apr 29. doi: 10.1002/alz.13769.
   

   >> Share

   
   
4. SASNER M, Preuss C, Pandey RS, Uyar A, et al
   In vivo validation of late-onset Alzheimer's disease genetic risk factors.
   Alzheimers Dement. 2024 Apr 30. doi: 10.1002/alz.13840.
   

   >> Share

   
   
5. FONTEH AN, Wu X, Astraea N, Elenberger T, et al
   Biomarkers - Part 1.
   Alzheimers Dement. 2023;19 Suppl 14:e079861.
   

   >> Share

   
   
6. 
   2024 Alzheimer's disease facts and figures.
   Alzheimers Dement. 2024 Apr 30. doi: 10.1002/alz.13809.
   

   >> Share

   
   
7. HU HY, Hu H, Jiang J, Bi YL, et al
   Echocardiographic measures of the left heart and cerebrospinal fluid biomarkers of Alzheimer's disease pathology in cognitively intact adults: The CABLE study.
   Alzheimers Dement. 2024 Apr 27. doi: 10.1002/alz.13837.
   

   >> Share

   
   

   
   Ann Neurol

8. LAN G, Chen X, Yang J, Sun P, et al
   Microglial Reactivity Correlates with Presynaptic Loss Independent of beta-Amyloid and Tau.
   Ann Neurol. 2024;95:917-928.
   

   >> Share

   
   

   
   Brain

9. SANCHEZ-JUAN P, Valeriano-Lorenzo E, Ruiz-Gonzalez A, Pastor AB, et al
   Serum GFAP levels correlate with astrocyte reactivity, post-mortem brain atrophy and neurofibrillary tangles.
   Brain. 2024;147:1667-1679.
   

   >> Share

   
   
10. DING F, Sun Q, Long C, Rasmussen RN, et al
    Dysregulation of extracellular potassium distinguishes healthy ageing from neurodegeneration.
    Brain. 2024;147:1726-1739.
    

    >> Share

    
    

    
    Brain Res

11. FOROUGHI S, Shahanipour K, Monajemi R, Ahadi AM, et al
    Investigating the effects of Thymus vulgaris essential oil, Allium cepa extract, and their active compounds (thymol and quercetin) on expression profile of genes related to Alzheimer's disease in PC12 model cell.
    Brain Res. 2024 Apr 28:148966. doi: 10.1016/j.brainres.2024.148966.
    

    >> Share

    
    
12. NEFODOVA A, Rudyk M, Dovhyi R, Dovbynchuk T, et al
    Systemic inflammation in Abeta(1-40)-induced Alzheimer's disease model: New translational opportunities.
    Brain Res. 2024;1837:148960.
    

    >> Share

    
    
13. XIE Y, Li X, Shi Q, Le L, et al
    The synergistic effect of curcumin and mitoquinol mesylate on cognitive impairment and the neuropathology of Alzheimer's disease.
    Brain Res. 2024;1837:148959.
    

    >> Share

    
    

    
    J Alzheimers Dis

14. CRESSOT C, Vrillon A, Lilamand M, Francisque H, et al
    Psychosis in Neurodegenerative Dementias: A Systematic Comparative Review.
    J Alzheimers Dis. 2024;99:85-99.
    

    >> Share

    
    
15. MORROW CB, Pontone GM
    Exploring Psychosis in Neurodegenerative Dementia: Connecting Symptoms to Neurobiology.
    J Alzheimers Dis. 2024;99:101-103.
    

    >> Share

    
    
16. HORVATH A, Quinlan P, Eckerstrom C, Aberg ND, et al
    The Associations Between Serum Insulin-like Growth Factor-I, Brain White Matter Volumes, and Cognition in Mild Cognitive Impairment and Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231026.
    

    >> Share

    
    
17. XU J, Chen Y, Shi Y, Sun A, et al
    Associations Between Neuroinflammation-Related Conditions and Alzheimer's Disease: A Study of US Insurance Claims Data.
    J Alzheimers Dis. 2024 Apr 30. doi: 10.3233/JAD-231286.
    

    >> Share

    
    
18. CHU Y, Xie Q, Meng R, Leng B, et al
    Evaluation of the Quality and Readability of Online Information about Alzheimer's Disease in China.
    J Alzheimers Dis. 2024 Apr 21. doi: 10.3233/JAD-231339.
    

    >> Share

    
    
19. LI Y, Yang Z, Zhang Y, Liu F, et al
    Genetic Screening of Patients with Sporadic Alzheimer's Disease and Frontotemporal Lobar Degeneration in the Chinese Population.
    J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-231361.
    

    >> Share

    
    
20. OHNO M
    A Strategy for Allowing Earlier Diagnosis and Rigorous Evaluation of BACE1 Inhibitors in Preclinical Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-231451.
    

    >> Share

    
    
21. WU B, Chen M, Meng L, Tian Q, et al
    Osteoclasts Link Dysregulated Peripheral Degradation Processes and Accelerated Progression in Alzheimer's Disease.
    J Alzheimers Dis. 2024 Apr 29. doi: 10.3233/JAD-240096.
    

    >> Share

    
    
22. GALE SA
    Language and Meaning: Asymptomatic Alzheimer's Disease in the Clinic and Society.
    J Alzheimers Dis. 2024 Apr 27. doi: 10.3233/JAD-240195.
    

    >> Share

    
    
23. ALROUJI M, Yasmin S, Furkan M, Alhumaydhi FA, et al
    Unveiling the Molecular Interactions Between Human Transferrin and Limonene: Natural Compounds in Alzheimer's Disease Therapeutics.
    J Alzheimers Dis. 2024;99:333-343.
    

    >> Share

    
    

    
    J Biol Chem

24. DUAN P, El Mammeri N, Hong M
    Milligram-Scale Assembly and NMR Fingerprint of Tau Fibrils Adopting the Alzheimer's Disease Fold.
    J Biol Chem. 2024 Apr 26:107326. doi: 10.1016/j.jbc.2024.107326.
    

    >> Share

    
    
25. PERRIN F, Sinha P, Mitchell SPC, Sadek M, et al
    Identification of PS1/gamma-secretase and glutamate transporter GLT-1 interaction sites.
    J Biol Chem. 2024;300:107172.
    

    >> Share

    
    

    
    J Neurol

26. CANU E, Rugarli G, Coraglia F, Basaia S, et al
    Real-word application of the AT(N) classification and disease-modifying treatment eligibility in a hospital-based cohort.
    J Neurol. 2024;271:2716-2729.
    

    >> Share

    
    
27. HUANG M, Landin-Romero R, Matis S, Dalton MA, et al
    Longitudinal volumetric changes in amygdala subregions in frontotemporal dementia.
    J Neurol. 2024 Jan 24. doi: 10.1007/s00415-023-12172.
    

    >> Share

    
    

    
    Neurobiol Dis

28. RODRIGUES MES, Bolen ML, Blackmer-Raynolds L, Schwartz N, et al
    Diet-induced metabolic and immune impairments are sex-specifically modulated by soluble TNF signaling in the 5xFAD mouse model of Alzheimer's disease.
    Neurobiol Dis. 2024 Apr 24:106511. doi: 10.1016/j.nbd.2024.106511.
    

    >> Share

    
    

    
    Neurology

29. LEWIS A, Galetta S
    Editors' Note: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
    Neurology. 2024;102:e209376.
    

    >> Share

    
    
30. CHIABOTTI PS, Rouaud O, Allali G
    Reader Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
    Neurology. 2024;102:e209375.
    

    >> Share

    
    
31. VASSILAKI M, Pittock RR, Aakre JA, Castillo AM, et al
    Author Response: Eligibility for Anti-Amyloid Treatment in a Population-Based Study of Cognitive Aging.
    Neurology. 2024;102:e209377.
    

    >> Share

    
    

    
    Neurology (Chic)

32. PEREZ FP, Morisaki J, Kanakri H, Rizkalla M, et al
    Electromagnetic Field Stimulation Therapy for Alzheimer's Disease.
    Neurology (Chic). 2024;3:1020.
    

    >> Share

    
    

    
    PLoS Biol

33. ETELEEB AM, Novotny BC, Tarraga CS, Sohn C, et al
    Brain high-throughput multi-omics data reveal molecular heterogeneity in Alzheimer's disease.
    PLoS Biol. 2024;22:e3002607.
    

    >> Share

    
    
34. ZENG W, Li C, Wu R, Yang X, et al
    Optogenetic manipulation of lysosomal physiology and autophagy-dependent clearance of amyloid beta.
    PLoS Biol. 2024;22:e3002591.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share